Whalegun
Home

Richard A. Heyman, Director: Enliven Therapeutics ELVN Sell · Filed 02/19

Trade details

Type
Insider sale
Amount
$32,201.4
Shares · price
1,230 sh · $26.18 a share
Held after
22,647 sh
Stock
Enliven Therapeutics ELVN
Person
Richard A. HeymanDirector
Trade date
26/02/17
Filed
26/02/19
Days to filing
2 days

Sold 5.2% of holdings

Share of holding sold
5.2%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 01/18~03/19

Richard A. Heyman's recent trades

  • Richard A. Heyman

    Planned saleEnliven Therapeutics

    $2.3M

    Filed 09/04

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $84K

    Filed 07/06

  • Richard A. Heyman

    Planned sale10b5-1 planOric Pharmaceuticals

    $76.8K

    Filed 07/06

  • Richard A. Heyman

    Planned sale10b5-1 planEnliven Therapeutics

    $32.9K

    Filed 02/17

  • Richard A. Heyman

    Sell10b5-1 planEnliven Therapeutics

    $19.4K

    Filed 01/22